Both smoking and hypertrophic cardiomyopathy (HCM) increase your risk of negative cardiovascular outcomes. By quitting cigarettes, you can support your HCM management plan. Hypertrophic ...
Capricor Therapeutics has completed its US marketing application for deramiocel, a cell therapy the US biotech hopes will become the first approved treatment for cardiomyopathy associated with ...
Making the choice between buying a new Apple MacBook Air vs MacBook Pro buying decision is trickier than ever because while both are great laptops, they excel at different things and come in a ...
The study presents valuable findings regarding the incidence and clinical impact of a mutation in a cardiac muscle protein and its association with the development of atrial fibrillation. The authors ...
Clinical and genetic predispositions are significant in predicting atrial fibrillation (AF); however, their role in patients with hypertrophic cardiomyopathy (HCM) remains unclear. This study aims to ...
Bonus--Jan 13, 1971 Bonus Ratio: 4 share(s) for every 5 shares held Bonus--Bonus Ratio: 1 share(s) for every 10 shares held Bonus--Bonus Ratio: 1 share(s) for every 2 shares held DCM Ltd., ...
Despite insufficient evidence to support direct-to-consumer genetic testing in routine clinical care, cardiovascular clinicians increasingly face questions about its utility and interpretation because ...
doctors.org.uk Objective To determine the incidence, demography and prognosis of vitamin D deficiency dilated cardiomyopathy (DCM) in Scotland over the last decade. Study design A retrospective review ...